　　 食品伙伴网讯2022�?�?2日，欧盟食品安全局＇�a href='//www.sqrdapp.com/news/tag_10.html' class='zdbq' title='EFSA相关食品资讯' target='_blank'>EFSA）发布消息，欧盟食品安全局转基囟�/a>作物专家组（ GMO）评估了转基囟�a href='//www.sqrdapp.com/news/tag_2319.html' class='zdbq' title='玉米相关食品资讯' target='_blank'>玉米MIR162的授权更新申请�

　　经过评估，GMO小组得出结论，更新申请EFSA-GMO-RX-025中没有证据表明有新的危害、修改后的暴露量以及科学不确定性会改变转基因玉米MIR162的原始风险评估结论。部分原文报道如下：

　　Following the submission of application EFSA-GMO-RX-025 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the co ntext of the renewal of authorisation application for the insect-resistant genetically modified maize MIR162, for food and feed uses, excluding cultivation within the EU. The data received in the co ntext of this renewal application co ntained post-market enviro nmental mo nitoring reports, a systematic search and e valuation of literature, updated bioinformatic analyses, and additio nal docu ments or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the co ntext of the original application. The GMO Panel co ncludes that there is no evidence in renewal application EFSA-GMO-RX-025 for new hazards, modified exposure or scientific uncertainties that would change the co nclusions of the original risk assessment on maize MIR162.

　　本文由食品伙伴网食品资讯中心编辑，有任何疑问，请联系news@www.sqrdapp.com、�/span>

? 欧盟食品安全局就锰的安全摄入量发表科学意见
? 欧盟食品安全局发布2022年传染性海绵状脑病监测	? 欧盟评估α-半乳糖苷酶和内切-1,4-β-葡聚糖酶	? 欧盟食品安全局更新嘧菌胺农药风险评估的同行诃�/a>

欧盟评估转基因玉米MO	美国FDA拟制定一种新
欧盟评估一种麦芽糖淀	美国拟撤销若干肉类叉�/a>

欧盟评估转基因玉米MIR162的授权更新申诶�/h1> 时间�?022-09-23 10:01 来源：食品伙伴网 作者： 泽夕

相关政策解读